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Abstract Sphingosine kinase-1 (Sphk1-1, EC 2.7.1.91) is a
regulator of pro-survival signalling, and its alterations have
been observed in Alzheimer’s disease, brain ischemia and
other neurological disorders. In this study we addressed the
question whether Sphk1 and its product, sphingosine-1-
phosphate (S1P), play a significant role in glucose deprivation
(GD)/glucose reload (GR) stress in hippocampal neuronal
cells (HT22). It was found that GD (6 h) followed by 24 h
of GR evoked enhancement of the free radical level and
neuronal HT22 cell death. Moreover, the significantly stron-
ger gene expression for the pro-apoptotic Bax protein and
down-regulation of the anti-apoptotic Bcl-2 and Bcl-XL pro-
teins were observed. Concomitantly, this stress up-regulated:
gene expression, protein level and activity of Sphk1.
Exogenous S1P at 1 μM concentration and the other agonists
of the S1P1 receptor (SEW 2871 and P-FTY720) enhanced
HT22 cell viability affected by GD/GR stress. This mecha-
nism is mediated by S1P receptor(s) signalling and by the
activation of gene expression for Bcl-2 and Bcl-XL.
Summarising, our data suggest that sphingolipid metabolism
may play an important role in the early events that take place
in neuronal cell survival/death under GD/GR stress. Our data
demonstrate that exogenous S1P, through the activation of
specific receptors S1P1 and S1P3 signalling pathways,
regulates the gene expression for anti-apoptotic proteins and
enhances neuronal cell survival affected by GD/GR stress.
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Introduction
Homeostasis of blood and cellular glucose is very important for
the functioning of the central nervous system (CNS). Moderate
hypoglycemia impairs neuronal functions, but severe hypogly-
cemia causes the death of vulnerable cells [1–3]. Despite in-
tense efforts in research, the mechanism of neuronal cell death
evoked by glucose deprivation (GD) followed by glucose
reload (GR) is not yet fully understood. Previous data indicated
the important role of excitotoxicity, but several other molecular
events have also been suggested. It was observed that hypo-
glycemia induces a several-fold increase in glutamate and
aspartate concentrations in the brain extracellular space [4].
Adenosine, which may reduce neuronal activity, can also in-
crease during hypoglycemia [5, 6]. In addition, a Ca2+ and Zn2+
influx, production of reactive oxygen (ROS) and nitrogen
(RNS) species and mitochondrial failure have been described
to be associated with hypoglycemic neuronal damage [7, 8].
Studies on the regulation of cell survival and death pre-
sented recently focused on the important role of bioactive
sphingolipids in these processes. Many data have shown the
signalling functions of two sphingolipids, ceramide and
sphingosine-1-phosphate (S1P). Numerous studies demon-
strated that level of ceramide is enhanced by a variety of cell
stressors. It was reported to increase along with brain aging,
ischemia and in neurodegenerative disorders [9–12]. A high
level of ceramides can be responsible for cell growth arrest
and apoptosis [13, 14]. However, S1P may promote cell
survival and proliferation [15, 16]. The balance between these
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two lipids (ceramide/S1P), which has been called the
“sphingolipid-rheostat”, is controlled by sphingosine kinases
(Sphk) [16, 17]. There are two isoforms of sphingosine ki-
nases, Sphk1 and Sphk2, whose activities can be a crucial
determinant of cell fate in stress responses.
S1P is implicated in both extracellular and intracellular-
mediated signalling. S1P synthesized in the cell by sphingo-
sine kinases is released, via the ABC family of transporters
from the cell and is able to act in an autocrine or paracrine
manner [18, 19]. The intracellular actions of S1P have been
recently identified [20–24], for example nuclear S1P synthe-
sized by sphingosine kinase 2 binds to and inhibits HDAC1
and HDAC2. Their inhibition by S1P prevents histone
deacetylation and enhanced transcription of the genes
encoding the cyclin-dependent kinase inhibitor p21 and the
transcriptional regulator c-fos [20]. Also, intracellular S1P
generated by sphingosine kinase 1 was shown to be necessary
for TRAF2 E3 ubiquitin ligase activity, which is essential for
TNF-mediated events [21].
The majority of S1P biological effects are known to be
mediated by the activation of five specific G protein-coupled
receptors (S1PR1–5) located on the cell surface. The S1P
signalling through these receptors causes the activation of
different downstream targets including: the Ras/ERK pathway
to promote proliferation, the PI3K/Akt signalling to prevent
apoptosis and the PI3K/Rac pathway involved with cytoskel-
etal rearrangement [24, 25].
Production of ROS can differently modulate Sphk1 and
Sphk2 activity, depending on the severity of oxidative damage
and the type of stress (ischemia, hypoxia and amyloid beta
toxicity) [26–28]. Enhancement of Sphk1 activity at an early
stage of stress signalling has a pro-survival effect by produc-
ing S1P and decreasing the ceramide concentration [29].
Sphk1/S1P can regulate cell viability and death bymodulating
the level of the Bcl-2 protein family [30, 31]. Until today,
nothing is known about the role of Sphk1/S1P in GD/GR
stress in hippocampal neuronal cells. The in vivo studies have
indicated that hypoglycemic neuronal death is pronounced in
hippocampal CA1, in the subiculum and dentate granule cell
layer [32].
In our study we used mouse immortalised hippocampal
neuronal cells (HT22) which had been already very well
described [33] and widely applied in a large number of stud-
ies. The aim of this study was to examine the role of S1P in
neuronal cell death evoked by GD/GR stress.
Experimental Procedures
Cell Culture
The studies were carried out using the mouse immortalised
hippocampal nerve cell line HT22, which is a subclone of
HT4. HT4 cells were immortalised from primary mouse hip-
pocampal neurons using a temperature-sensitive small virus-
40 T antigen [34, 35]. These cells retain the characteristics of
differentiated neurons. HT22 cells were obtained from
Professor David Schubert, Salk Institute, La Jolla, CA, USA.
This cell line does not possess active ionotropic glutamate
receptors and was very well described by Sagara and Schubert
[33]. In accordance with this publication [33] HT22 cells
express functional group I metabotropic glutamate receptors
(mGluR1 and mGluR5). We recently used it extensively for
different types of studies [36]. HT22 cells were cultured in 75-
cm2 flasks in DMEM supplemented with 10 %-heat-
inactivated fetal bovine serum (FBS), 1 % penicillin/
streptomycin (50 U/ml) and 2 mM glutamine. Cells were
maintained at 37 °C in a humidified incubator containing
5 % CO2. The HT22 cells were used for experiments between
five and ten passage numbers. We kept HT22 cells at no
greater than 50 % confluence. HT22 cells were seeded onto
96-well plate at a density of 2×103 cells per well in 100 μl of
medium. HT22 cells were seeded at 3×105 cells/10-mm tissue
culture dish.
Glucose Deprivation/Glucose Reload
Equal cell numbers were seeded into 48-well or 96-well
0.1 % polyethyleneimine coated plates. After 24 h the cells
were rinsed two times with phosphate-buffered saline
(PBS) and treated with low-serum (2 % FBS) glucose-
free medium (Gibco, Invitrogen). GD was terminated after
6 h by exchanging the glucose-free medium to low-serum
(2 % FBS) Dulbecco’s modified Eagle medium (DMEM)
supplemented with 25 mM glucose. The extent of cell
death was assessed after a 24 h GR period by using
MTT assay. S1P (1 μM) was added concomitantly with
the initiation of GD. The cells were incubated with S1P
(1 μM) under GD conditions and also during the recovery
period. Osmolarity of the medium used in this study was
measured by using the Osmomat 030 – Gonotec.
Osmolarity determined in the glucose-free medium in either
the absence and presence of 25 mM mannitol indicated
small changes in osmolarity in the HT22 cells.
Cell Viability Analysis
Mitochondrial function and cellular viability were evaluated
using 2-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT). After 6 h GD/24 hGR incubation with the
appropriate compounds, MTT (2.5 mg/ml) was added to all of
the wells. The cells were incubated at 37 °C for 2 h. Then the
cells were lysed in DMSO and spectrophotometric measure-
ment was performed at 595 nm.
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Determination of Free Radicals Using DCF Probe
ROS production in HT22 cells was assessed by using the 2′,7′-
dichlorodihydrofluorescein diacetate (H2DCF-DA) probe
[37, 38]. Cell media was changed after 6 h GD/24 h GR to
Hanks’ buffer and incubation was continued in the presence of
10 μM H2DCF-DA for 50 min at 37 °C. Then fluorescence
(excitation [λex], 485 nm; emission [λem], 535 nm) was
quantified.
Determination of Gene Expression
Cells were washed twice with ice-cold PBS, scraped from the
culture dish and centrifuged shortly (3 min, 1,000×g). RNA
was isolated from the cell pellet by using TRI reagent accord-
ing to the manufacturer’s protocol (Sigma, St. Louis, MO,
USA). Digestion of DNA contamination was performed by
using DNase I according to the manufacturer’s protocol
(Sigma). RNA quantity and quality were controlled by spec-
trophotometric analysis and gel electrophoresis. Reverse tran-
scription was performed by using a High Capacity cDNA
Reverse Transcription Kit according to the manufacturer’s
protocol (Applied Biosystems, Foster City, CA, USA).
Quantitative real time PCR was performed by using the fol-
lowing pre-developed TaqMan Gene Expression Assays
(Applied Biosystems): Bcl-2-Mm00477631_m1, Bcl211-
Mm00437783_m1, Bax-Mm00432051_m1, Sphk1-
Mn00448841_g1, Actb-Mm00607939_s1 on an ABI
PRISM 7500 apparatus according to the manufacturer’s in-
structions. Actin (Actb) was selected and used in all of the
studies as a reference gene. The level of mRNAwas calculated
by ΔΔCt method.
Immunochemical Determination of Protein Level
(Western Blot)
After protein measurement according to Lowry, the homoge-
nate of the HT22 cells was mixed with a 5×Laemmli sample
buffer and denatured for 5 min at 95 °C. Then, 40 μg of
protein was loaded per lane on 10 % acrylamide gels and
examined by SDS–PAGE. The proteins were transferred onto
PVDF membranes at 100 V. Membranes were incubated in
5 % dry milk in TBS with Tween 20 (TBS-T) for 1 h and
exposed overnight to the following antibodies: anti-Sphk1
(1:250, from Cell Signaling) and anti-GAPDH (1:4,000, from
Sigma Aldrich). After treatment for 1 h with the correspond-
ing horseradish peroxidase-coupled secondary antibodies
(anti-rabbit from Sigma-Aldrich), the protein bands were de-
tected by ECL reagent (ThermoScientific).
Fig. 1 Effect of GD/GR on
HT22 cell viability (a), ROS
generation (b) and gene
expression of pro- and anti-
apoptotic Bcl-2 proteins (c). Data
represent mean values±SEM for
four separate experiments with
four to six replications (a) and for
three separate experiments with
three replications (b, c).
***p<0.001 versus control [c]
HT22 cells by Student’s t-test
(a, b), ***p<0.001, **p<0.01
versus control [c] HT22 cells by
one-way ANOVA followed by
the Newman–Keuls test (c)
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Measurement of Sphk Activity
Sphk activity assay was performed according to a previous
report [23]. After 24 h incubation, the cells were washed with
iced PBS and lysed by a freeze–thaw cycle in 50 mMHEPES,
pH 7.4, 10 mM KCl, 15 mM MgCl2, 0.1 % Triton X-100,
20 % glycerol, 2 mM orthovanadate, 2 mM dithiothreitol,
10 mM NaF,1 mM deoxypyridoxine, and EDTA-free com-
plete protease inhibitor (Roche Applied Science). Lysates
were cleared by centrifugation at 15,000 rpm for 5 min. The
lysates and NBD-Sphingosine (10 μM final; Avanti Polar
Lipids) were mixed in a reaction buffer (50 mM HEPES,
pH 7.4, 15 mM MgCl2, 0.5 mM KCl, 10 % glycerol and
2 mM ATP) and incubated for 30 min at 30 °C. The reactions
were stopped by the addition of an equal amount of 1 M
potassium phosphate, pH 8.5, followed by an addition of
2.5-fold chloroform/methanol (2:1), and then centrifuged at
15,000 rpm for 1 min. Only the reactant NBD-S1P, but not the
substrate NBD-Sphingosine, was collected in the alkaline
aqueous phase. The fluorescence value was measured (λex=
485 nm, λem=538 nm) after the aqueous phase was combined
with an equal amount of dimethylformamide [39].
Determination of Apoptosis
Apoptosis was determined by Hoechst 33342 fluorescent stain-
ing. The cells were examined under a fluorescence microscope
(Olympus BX51, Japan) and photographed with a digital cam-
era (Olympus DP70, Japan). Cells with typical apoptotic nu-
clear morphology (nuclear shrinkage, condensation) were iden-
tified and counted. The results were expressed as percentages
of apoptotic cells in the whole cell population.
Fig. 2 Sphingosine kinase
activity, gene expression and
protein level in hippocampal
neuronal cells subjected to GD/
GR stress. Data represent the
mean value±SEM for three
separate experiments with three
replications; *p<0.05 versus
control [c] HT22 cells by
Student’s t-test (a, c). The
absolute value of Sphk1 activity
in control HT22 cells is 2655
[AU]. The absolute value of
Sphk1 activity in GD/GR treated
HT22 cells is 3044 [AU]. Data
represent the mean value±SEM
for three separate experiments
normalised against GAPDH,
**p<0.01 versus control [c]
HT22 cells by Student’s t-test (b)
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Statistical Analysis
The results were expressed asmean values±SEM. Differences
between means were analysed using Student’s t-test or one-
way ANOVA followed by the Newman-Keuls test. Values of
p<0.05, p<0.01 and p<0.001 were considered statistically
significant.
Results
GD (6 h) followed by GR (24 h) decreased the viability of
HT22 cells by about 30 %. The effect of osmotic changes on
these cells’ survival was negligible. Our study presented that
GD/GR leads to: significant cell death, enhancement of the
free radical level and changes in the gene expressions of pro-
and anti-apoptotic Bcl-2 proteins (Fig. 1a,b,c). Gene expres-
sion of the Hrk protein was observed at a very low level and
was not altered by GD/GR (data not shown). GD/GR stress
enhanced the gene expression, protein level and activity of
Sphk1 (Fig. 2a,b,c).We also observed that exogenously added
S1P significantly suppressed oxidative stress and increased
HT22 cell survival affected by GD/GR (Fig. 3a,b).
Microscopic examination of cell nuclei stained with DNA-
binding fluorochrome Hoechst 33342 showed that HT22 cells
exposed to GD/GR presented typical apoptotic morphology.
The protective effect of S1P was seen in this fluorescence
microscope study. This bioactive lipid significantly decreased
death signalling evoked by GD/GR and the amount of apo-
ptotic cells (Fig. 3c). Exogenous S1P at a concentration of
1 μM significantly enhanced the expression of Bcl-2 and Bcl-
XL, both anti-apoptotic proteins suppressed by GD/GR.
However, S1P did not alter GD/GR-evoked changes of Bax
(Fig. 4a,b,c). Finally, we investigated whether the S1P effect is
receptor-mediated. Using S1P receptor agonists, i.e., S1P,
SEW 2871 (a specific agonist for S1P1) and P-FTY720 (an
agonist for S1P1, S1P3, S1P4, S1P5), we demonstrated that
the neuroprotective effect of S1P is mediated by activation of




Fig. 3 Effect of sphingosine-1-
phosphate on HT22 cell viability
(a) and ROS generation (b) after
exposure to GD/GR. Data
represent the mean value±SEM
for four separate experiments with
four to six replications (a) and for
three separate experiments with
three replications (b).
***p<0.001 versus control [c]
HT22 cells, ###p<0.001 versus
GD/GR-treated cells by one-way
ANOVA followed by the
Newman–Keuls test. Apoptosis
induced by GD/GR and the
protective effect of S1P in HT22
cells (c). The number of apoptotic
cells was counted. Data represent
the mean value±SEM for three
separate experiments with three
replications, ***p<0.001 versus
control [c] HT22 cells,
###p<0.001 versus GD/GR-
treated cells by one-way ANOVA
followed by the Newman–Keuls
test. The arrows indicate nuclei
with typical apoptotic features
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using antagonists for S1P1 and S1P3 (VPC23019) and the
specific antagonist for S1P1 (W123). Cell survival analysis
indicated that both compounds abolished the protective effect
of S1P on HT22 cells (Fig. 5b). Gene expression analysis
demonstrated that the mRNA level of S1P3 under GD/GR
stress was significantly increased and that the mRNA level of
S1P1 was not changed (Fig. 5c). Based on these results we
propose that the neuroprotective effect of S1P is mainly de-
pendent on S1P1 and S1P3 receptor stimulation.
Discussion
Although there are growing evidences that S1P receptor sig-
nalling may be neuroprotective in AD, brain injury, ischemia
and other neurological disorders [40–44], there is limited data
about its involvement in GD/GR stress. In this study, we used
an in vitro model of metabolic-oxidative stress evoked by GD
followed by GR, which is observed in the pathological condi-
tions as mentioned above. GD/GR leads to a significant en-
hancement of free radical concentrations and HT22 hippocam-
pal neuronal cell death. These experimental conditions enhance
gene expression for the pro-apoptotic protein Bax and concom-
itantly decrease expression for Bcl-2 and Bcl-XL. Our study
indicated for the first time, that the expression of Sphk1, the
enzyme involved in pro-survival signalling [45, 46], was sig-
nificantly increased. However, endogenous synthesis of S1P
was not able to protect cells against death. Our study indicated
the neuroprotective effect of exogenously applied S1P at a
concentration of 1 μM on death signalling in HT22 cell ex-
posed to GD/GR stress. A higher concentration of S1P (10 and
30 μM) induced cell death from about 50 % to 80 %, respec-
tively (data not shown), probably through its degradation to
sphingosine and ceramide. S1P, the product of Sphk1/2 activ-
ity, is a bioactive lipid mediator that promotes cell survival,
proliferation, migration and angiogenesis. Disturbances in gene
expression for Sphk1/Sphk2 and sphingosine-1-phosphate re-
ceptor 1 (S1P1) were observed in the animal experimental
model of cerebral ischemia [47]. Spiegel andMilstien observed
that the S1P analogue (PFTY720) reduced neuronal injury,
possibly via S1P1 activation [47]. S1P may be also implicated
in the neuroprotective effect in acute brain and spinal cord
injury with regard to mitochondrial dysfunction and the oxida-
tive stress mechanism [48]. The other in vitro experiments
demonstrated that S1P inhibits apoptosis in response to oxida-
tive stress induced by H2O2 [49]. It was observed that this anti-
apoptotic effect of S1P is mediated through PI3K/Akt signal-
ling and is regulated through receptors S1P1 and S1P3. The
protective effect of S1P was abolished after treatment with
VPC23019, an antagonist of S1P1 and S1P3 receptors,
W146, an antagonist of S1P1 receptors, and CAY10444, an
antagonist of S1P3 receptors. According to our data the
neuroprotective effect of S1P is also mediated by acti-
vation of receptors S1P1 and S1P3 in GD/GR toxicity.
Fig. 4 Effect of GD/GR and S1P
on the expression of Bcl-2 (a),
Bcl-XL (b) and Bax (c) genes in
HT22 cells. Data represent the
mean value±SEM for three
separate experiments with three
replications,*p<0.05, **p<0.01,
***p<0.001 versus control
[c] HT22 cells, #p<0.05,
###p<0.001 versus GD/GR-
treated cells by one-way ANOVA
followed by the Newman–Keuls
test
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The S1P analogue P-FTY720 and the specific agonist of S1P1
(SEW2871) enhanced cell viability under GD/GR stress. It was
also reported that mitochondria are involved in neuroprotective
effect of S1P in oxygen-glucose deprivation model [50]. The
data obtained by Agudo-López et al. [50] pointed out that
S1P treatment significantly reduces both necrosis and apopto-
sis in the in vitro model of ischemia. The protection mecha
nism involved stabilisation of the mitochondrial membrane
potential, reduced calcium loading and decreased sensitivity
to mPTP opening. Our data suggest that the protective mecha-
nism of S1P is dependent on Bcl-2 proteins, which control a
critical step in commitment to apoptosis by regulating
permeabilisation of the mitochondrial outer membrane [51].
In our study, S1P regulated pro-survival signalling by en-
hancing expression of Bcl-2 and Bcl-XL; both anti-apoptotic
proteins suppressed by GD/GR. Consequently S1P may lead
to the stabilization of mitochondrial membrane potential and
reduce the ROS production. Anti-apoptotic Bcl-2 family
members (Bcl-2, Bcl-XL) have a well-described role in
scaffolding the Bcl-2 homology (BH3) domain of pro-
apoptotic Bcl-2-family members, thereby neutralising their
pro-apoptotic activity [52]. According to some other studies,
exogenous S1P regulate the expression of pro apoptotic and
anti apoptotic proteins. It has been observed that S1P in-
creases the expression of anti apoptotic Bcl-2 [53–55] and
Mcl1 [56] as well as down-regulates the pro apoptotic pro-
teins Bad and Bax [55, 57–59]. Overexpression of Sphk1 up-
regulates Bcl-2 and down-regulates B-cell lymphoma 2
interacting mediator of cell death (Bim) [30, 31]. Similarly,
overexpression of Sphk1 inhibits the activation of caspase 3,
cytochrome c and SMAC/Diablo release from mitochondria
through the modulation of Bim, Bcl XL and Mcl1 in chronic
myeloid leukaemia cells [29]. There are also evidences that
Bcl-2 overexpression may stimulate Sphk1 expression and
activity in human melanoma cells [60]. Our data indicate that
stimulating effect of S1P on the expression of anti-apoptotic
Bcl-2 proteins can be an important protective mechanism
against GD/GR stress.
Fig. 5 Effect of S1P analogue
P-FTY720, S1P1 receptor agonist
SEW2871 (a) and S1P receptor
(1,3) antagonists (VPC23019 and
W123) on HT22 cell viability (b),
***p<0.001 versus control [c]
HT22 cells, #p<0.05, ###p<0.001
versus GD/GR-treated cells,
$$p<0.01 versus S1P-pretreated
and GD/GR-treated cells by one-
way ANOVA followed by the
Newman–Keuls test. Effect of
GD/GR and S1P on the
expression of S1P1 and S1P3 (c).
Data represent the mean value±
S.E.M for three separate
experiments with three
replications, **p<0.001 versus
control [c] HT22 cells by
Student’s t-test
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